Status:
COMPLETED
Hemospec Device for Sepsis Diagnosis
Lead Sponsor:
University of Athens
Collaborating Sponsors:
General Hospital of Lamia
University of Jena
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A diagnostic devise, namely HemoSpec, had been developed that integrates clinical information, along with information on circulating protein biomarkers and the morphology of white blood cells to achie...
Detailed Description
Sepsis is a life-threating organ dysfunction resulting from the dysregulated response of the host to an infection. It is estimated that 1.5 million people present with sepsis annually in Northern Amer...
Eligibility Criteria
Inclusion
- Admission in the Emergency Department
- Age above or equal to 18 years old
- Both genders
- Written consent provided from patients or their first-degree relatives for patients unable to consent
- Considerable risk of death as indicated by the presence of at least one of the following: i) sudden alteration of mental status; ii) systolic blood pressure less than 100 mmHg; and iii) high respiratory rate defined as more than or equal to 22 breaths per minute.
Exclusion
- Known infection by the human immunodeficiency virus-1
- Acute myocardial infarction as evidenced by the electrocardiographic finding of ST- elevation.
- Single trauma or multiple injuries
- Known pregnancy and breastfeeding
- Patients with a life expectancy of less than 28 days and with limited treatment options
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT03350113
Start Date
October 2 2017
End Date
April 30 2018
Last Update
May 2 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Jena
Jena, Germany, 07743
2
General Hospital of Lamia
Lamia, Phthiotis, Greece, 35100
3
4th Department of Internal Medicine, ATTIKON University Hospital
Athens, Greece, 12462